JCJingfeng Chen

Jingfeng Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingfeng Chen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Cohort Study on Systemic Immune-Inflammation Index and Its Longitudinal Change in Relation to Colorectal Adenoma Recurrence

    by Yujie Sun, Jingfeng Chen, Jiaoyan Li, Jianan Shao, Weikang Li, Suying Ding

    This study aimed to investigate the associations of both baseline systemic immune-inflammation index (SII) and, more importantly, its longitudinal change (ΔSII) during follow-up with the risk of advanced colorectal neoplasia (ACRN) recurrence after endoscopic resection of colorectal adenomas. Clinical data from 1855 patients diagnosed with colorectal adenomas and undergoing resection at Hospital between January 2017 and August 2023 were analyzed. Patients were classified into Q1–Q4 groups based on baseline SII quartiles and into three groups according to ΔSII. Cox proportional hazards regression models, restricted cubic spline (RCS) analysis, Kaplan-Meier curves, receiver operating characteristic (ROC) curve, subgroup analysis, sensitivity analyses were used to evaluate associations. After an average follow-up of 3.4 years, 166 patients (8.95%) experienced ACRN recurrence. After fully adjusting for variables, Cox proportional hazards regression analysis revealed that the group with the highest baseline SII (Q4) had a 1.75-fold increased risk of ACRN recurrence compared to Q1 (HR, 1.75; 95% CI, 1.12–2.75). Patients with a significant SII increase (ΔSII > 0.15) had a 1.88-fold higher recurrence risk than those with a stable SII (−0.15 ≤ ΔSII ≤0.15) (HR, 1.88; 95% CI, 1.24–2.86). Dose-response curves indicated a rising ACRN recurrence risk when ΔSII ranged from 0.008 to 1.103, followed by a declining trend for ΔSII ≥ 1.103 (P-overall=0.003, P-nonlinear=0.005). ROC analysis showed that incorporating either SII levels or ΔSII grouping improved the predictive ability (AUC) for postoperative recurrence. Subgroup analyses confirmed that both a high baseline SII (Q4) and a significant SII increase (ΔSII > 0.15) were associated with elevated recurrence risk, particularly among males and older adults. Not only baseline SII but also ΔSII during follow-up serves as a significant and independent predictor for ACRN recurrence. Monitoring the longitudinal change of SII may provide incremental clinical value for optimizing personalized surveillance strategies after endoscopic resection.

  • Open Access

    Joint Associations of the Geriatric Nutrition Risk Index and Frailty with All-Cause and Cause-Specific Mortality in Diabetes Patients: A Prospective Cohort Study

    by Chenke Gu, Qiuyue Jia, Youxiang Wang, Weikang Li, Suying Ding, Jingfeng Chen

    Background: This study investigated the independent and joint impacts of the geriatric nutritional risk index (GNRI) and frailty index (FI) on all-cause and cause-specific mortality in patients with diabetes.Methods: This study included 1,790 National Health and Nutrition Examination Survey participants between 1999 and 2018. GNRI and FI were used to assess patients with diabetes, who were categorized into low GNRI and high GNRI groups, as well as low FI and high FI groups, to evaluate older adults’ nutritional status. These groups were combined into four categories. Weighted Cox proportional hazards models, Kaplan-Meier survival curves, and restricted cubic spline regression models were applied to assess the independent and joint associations of GNRI and FI with all-cause and cause-specific mortality in patients with diabetes.Results: The median follow-up period was 100 months, during which 720 deaths occurred. An independent linear dose-response relationship between GNRI, FI, and all-cause mortality risk was observed. The combination of low GNRI and high FI was significantly associated with increased risk of all-cause mortality (hazard ratio, 1.65; 95% confidence interval [CI], 1.02 to 2.68) for the low GNRI+low FI group, 2.03 (95% CI, 1.61 to 2.55) for the high GNRI+high FI group, and 3.65 (95% CI, 2.38 to 5.58) for the low GNRI+high FI group. Stratified analysis (reference: high GNRI+low FI group) showed an increased mortality risk among men in the low GNRI+high FI group.Conclusion: The combination of low GNRI and high FI was independently and jointly associated with increased risk of all-cause, cardiovascular disease, diabetes, and hypertension mortality, particularly among men.


  • Open Access

    Identifying sleep patterns as a synthetic signature in metabolic comorbidities using a stratified medicine approach

    by Shizhen Zhang, Qian Qin, Zhuoqing Wu, Lin Wang, Suying Ding, Jingfeng Chen

    Abundant evidence suggests that sleep is closely associated with metabolic diseases. However, studies focusing on sleep patterns in relation to metabolic comorbidities defined as the coexistence of obesity, type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, hyperuricemia, and non-alcoholic fatty liver disease (NAFLD) remain limited. This study aimed to explore the association between sleep patterns and both metabolic comorbidities and individual metabolic diseases using novel analytical methods. A total of 4,970 participants was included. Four sleep-related factors and six metabolic diseases were examined. Multiple correspondence analysis (MCA), K-means clustering, logistic regression, and subgroup analysis were applied to assess associations between sleep patterns and metabolic conditions. MCA and clustering of sleep factors identified three categories of sleep patterns: good sleep pattern (GSP), intermediate sleep pattern (ISP), and poor sleep pattern (PSP). Within the PSP group, 77.9% had a late bedtime, 83.7% reported poor or very poor sleep quality, 90.4% slept fewer than 7 h per night, and 29.1% snored. After adjusting for sex, age, and other confounders, PSP was associated with a 34.5% higher odds of metabolic comorbidities compared with GSP, with an even stronger association observed in men (51.9%). ISP was not associated with metabolic comorbidities overall, but was associated with increased odds of T2DM (19.4%) and NAFLD (23.4%). Specific sleep factors, including consistently having a late bedtime and snoring, were associated with higher odds of metabolic comorbidities by 67.7% [OR (95%CI): 1.677 (1.059–2.658)] and 46.4% [OR (95%CI): 1.464 (1.179–1.819)], respectively. Mediation analysis indicated that body mass index (BMI) explained only 31.58% of the total effect of sleep patterns on comorbidity risk in men. Sleep factors aggregated into three prevalent sleep patterns, with strong internal correlations observed within each pattern. PSP was associated with increased odds of metabolic comorbidities, with this association being pronounced in all participants and men. Notably, BMI served as a partial mediator of this relationship in the male subgroup. ISP showed significant associations with T2DM and NAFLD, highlighting their clinical relevance. These findings emphasize the role of sleep in metabolic health and support the need for longitudinal sleep interventions and strategies to improve sleep conditions.


  • Open Access

    Association between the metabolic score for insulin resistance trajectory and new-onset metabolic syndrome: a retrospective cohort study based on health check-up data in China

    by Jianan Song, Su Yan, Youxiang Wang, Peimeng Zhu, Suying Ding, Jingfeng Chen

    The Metabolic Score for Insulin Resistance (METS-IR) is a novel biomarker for evaluation of insulin resistance (IR). Emerging evidence suggests this metric may be able to predict the onset of metabolic syndrome (MetS). The aim of this study was to determine whether there is a correlation between sustained METS-IR values and the future risk of MetS. Data for 3,750 individuals who attended a tertiary hospital in Zhengzhou for a health check-up between 2017 and 2022 were analyzed. The METS-IR was used to evaluate IR. A latent class trajectory model was created by dividing the subjects into high-stability and low-stability categories based on three consecutive years of data. The incidence of MetS between 2020 and 2022 was calculated using the Kaplan–Meier method and Cox regression modeling. Over a median follow-up of 2.13 years, we identified 430 cases of MetS (11.47%). The incidence rate was 35.48% in the high-stability group and 8.32% in the low-stability group (P < 0.001). Multivariate Cox regression, controlling for sex, age, hypertension status, diabetes status, and serum uric acid, low-density lipoprotein cholesterol, and gamma-glutamyl transferase levels, revealed that the risk of MetS was significantly higher in the high-stability group (hazard ratio [HR] = 4.77, 95% confidence interval [CI]: 3.714–6.126, P < 0.001). Stratified analysis by age showed that the risk of MetS was also significantly higher in individuals aged < 45 years (HR = 6.202, 95% CI: 4.312–8.921) and in those aged ≥ 45 years (HR = 3.89, 95% CI: 2.720–5.566) in the high-stability group. Receiver operating characteristic (ROC) curve analysis showed that the trajectory of METS-IR could predict MetS. The respective areas under the ROC curve for the 1-year, 2-year, and 3-year risk of MetS were 0.575, 0.641, and 0.628. Sensitivity analyses showed that an elevated METS-IR value was associated with an increased risk of new-onset MetS. In this study, there was a significant correlation between the METS-IR value and the future risk of MetS. METS-IR measurement over time may allow early detection of individuals at high risk of MetS, which would lessen the impact of chronic disease.


  • Open Access

    Unifying Diagnosis Identification and Prediction Method Embedding the Disease Ontology Structure From Electronic Medical Records

    by Jingfeng Chen, Chonghui Guo, Menglin Lu, Suying Ding

    Objective: The reasonable classification of a large number of distinct diagnosis codes can clarify patient diagnostic information and help clinicians to improve their ability to assign and target treatment for primary diseases. Our objective is to identify and predict a unifying diagnosis (UD) from electronic medical records (EMRs). Methods: We screened 4,418 sepsis patients from a public MIMIC-III database and extracted their diagnostic information for UD identification, their demographic information, laboratory examination information, chief complaint, and history of present illness information for UD prediction. We proposed a data-driven UD identification and prediction method (UDIPM) embedding the disease ontology structure. First, we designed a set similarity measure method embedding the disease ontology structure to generate a patient similarity matrix. Second, we applied affinity propagation clustering to divide patients into different clusters, and extracted a typical diagnosis code co-occurrence pattern from each cluster. Furthermore, we identified a UD by fusing visual analysis and a conditional co-occurrence matrix. Finally, we trained five classifiers in combination with feature fusion and feature selection method to unify the diagnosis prediction. Results: The experimental results on a public electronic medical record dataset showed that the UDIPM could extracted a typical diagnosis code co-occurrence pattern effectively, identified and predicted a UD based on patients' diagnostic and admission information, and outperformed other fusion methods overall. Conclusions: The accurate identification and prediction of the UD from a large number of distinct diagnosis codes and multi-source heterogeneous patient admission information in EMRs can provide a data-driven approach to assist better coding integration of diagnosis.